Wipro | Constant currency revenue declines 1.7% sequentially versus expectations of a 2.7% drop. March quarter guidance is for a revenue drop of 1.5% to revenue growth of 0.5%. MD & CEO Theirry Delaporte said that starting to see early signs of growth returning to consulting, as Capco business grew double-digits. The company's ADR ended 17% higher on Friday
HCLTech | US Dollar revenue up 6% sequentially in constant currency terms, beating estimates of 4% growth. Revenue guidance narrowed to 5% to 5.5% (including ASAP) from 5% to 6% earlier. EBIT margin guidance of 18% to 19% retained. New deal wins halve sequentially to $1.9 billion, down 18% year-on-year.
Tata Consumer Products | To acquire Capital Foods, the owner of Ching's Secret and Smith and Jones brands. The enterprise value on a no cash / no debt basis for 100% stake in Capital Foods is said to be ₹5,100 crore. 75% of the equity will be acquired immediately, while the remaining 25% will be acquired in the next three years. The company will also acquire Organic India for ₹1,900 crore. Organic India is in the business of packaged organic tea, herbal products and health supplements. Tata Consumer's board will meet on January 19 to consider fund raising via debt issue.
Avenue Supermarts | December quarter net profit up 17.6% to ₹690.6 crore, while revenue also grew 17.3% year-on-year. EBITDA grew by 16%, while margin remained flat at 8.2% Vs 8.3% last year. The company also opened a new store in Nagpur, taking the total count to 342.
E-Mudhra | Launches QIP to raise up to ₹200 crore. Sources tell CNBC-TV18 that the indicative issue price is ₹422 per share, which is a 9.5% discount to Friday's close. The company is seeking a dilution of up to 6.1% of pre-issue outstanding equity share capital.
Anant Raj | Launches QIP to raise up to ₹500 crore. Sources tell CNBC-TV18 that the issue price is said to be ₹296 per share, which is a 4.8% discount to the floor price. The QIP will result in a dilution of 4.95% of post-issue paid-up equity share capital. Anant Raj was also part of CNBC-TV18's dealing room chatter on Friday.
Lupin | Gets USFDA approval for Propranolol Hydrochloride Extended release capsules used in the treatment of hypertension, migraine and Angina Pectoris. The drug will be manufactured in the company's Pithampur facility. The drug had annual sales of $71 million in the US as of November 2023.
BHEL | Gets Letter of Award for Talabira Thermal Power Project worth ₹15,000 crore from NLC India. Order pertains to supply of equipment, boiler, turbine, generator and associated auxiliaries. Commissioning of project to be done within 64 months.